NEVRO CORP - NOTE 2.750% 4/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2020 to Q1 2025

Type / Class
Debt / NOTE 2.750% 4/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of NEVRO CORP - NOTE 2.750% 4/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2025 Q1 $0 $0 -$33,662,933 0
2024 Q4 $21,586,702 $33,662,933 -$5,446,152 97.86% 5
2024 Q3 $27,200,702 $38,866,165 -$3,640,879 97.01% 7
2024 Q2 $30,950,702 $42,158,239 +$5,811,157 96.65% 9
2024 Q1 $27,336,702 $36,190,904 -$10,276,260,999 94.75% 7
2023 Q4 $37,028,000 $35,092,552 -$131,993,375 94.75% 7
2023 Q3 $178,042,702 $176,921,200 +$159,924 93.58% 11
2023 Q2 $178,021,702 $174,744,275 +$2,652 92.44% 12
2023 Q1 $178,031,689 $177,212,353 +$719,815 93.59% 13
2022 Q4 $179,030,689 $164,243,694 -$41,875,679 91.75% 13
2022 Q3 $114,978,689 $115,531,124 -$9,393,365 94.29% 14
2022 Q2 $131,973,000 $124,401,000 -$62,611,526 93.19% 14
2022 Q1 $193,492,000 $207,649,000 +$5,569,505 107.16% 17
2021 Q4 $184,727,000 $206,665,655 -$7,753,238 111.3% 15
2021 Q3 $187,245,191 $252,888,873 -$37,971,221 135.06% 19
2021 Q2 $187,147,000 $324,810,241 +$4,138,812 173.73% 22
2021 Q1 $185,061,000 $284,215,181 -$2,939,931 153.5% 22
2020 Q4 $187,301,000 $342,569,426 +$7,553,770 182.63% 23
2020 Q3 $185,113,000 $288,775,000 +$1,784,365 155.34% 23
2020 Q2 $183,965,002 $252,168,003 +$252,168,003 136.97% 25